Relative contribution of insulin secretion and sensitivity at different stages of glucose tolerance: Non-obese versus obese Japanese subjects

Internal Medicine

Volumn 53, Issue 5, 2014, Pages 383-390

  Iwao, Tadashi ^a   Sakai, Kenji ^a   Ando, Eiji ^a  

^a Iwao Hospital   (Japan)

Author keywords

Insulin secretion; Insulin sensitivity; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTATIC MODEL INSULIN RESISTANCE; HOMEOSTATICMODEL ASSESSMENT OF BETA CELL; HUMAN; INFORMATION PROCESSING; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SENSITIVITY INDEX; INSULINOGENIC INDEX; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; RADIOIMMUNOASSAY; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INCIDENCE; INSULIN RESISTANCE; PHYSIOLOGY; SECRETION (PROCESS);

BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; INSULIN; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; OBESITY;

EID: 84895151403     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.0337     Document Type: Article

References (30)

1. Lorenzo C, Wagenknecht LE, D'Agostino RB Jr, Rewers MJ, Karter AJ, Haffner SM. Insulin resistance, β-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study. Diabetes Care 33: 67-72, 2010.
2. Accili D. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53: 1633-1642, 2004.
3. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 30: 1988-1992, 1993.
4. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46: 63-69, 1997.
5. DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38: 387-395, 1989.
6. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368, 1992.
7. Tripathy D, Carlsson M, Almgren P, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49: 975-980, 2000.
8. Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20: 1562-1568, 1997.
9. Fukushima M, Usami M, Ikeda M, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a crosssectional study of Japanese type 2 diabetes. Metabolism 53: 831-835, 2004.
10. Iwahashi H, Okauchi Y, Ryo M, et al. Insulin-secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non-obese Japanese patients. J Diabetes Invest 3: 271-275, 2012.
11. Kosaka K, Kuzuya T, Hagura R. Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients. Diabetes Res Clin Pract 24(Suppl): S101-S110, 1994.
12. Kosaka K, Hagura R, Kuzuya T, Kuzuya N. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia 10: 775-782, 1974.
13. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44: 929-945, 2001.
14. Pratley RE, Weyer C. Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion. Curr Diab Rep 2: 242-248, 2002.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35: S64-S71, 2012.
16. Iwao T, Sakai K, Ando E. Upper limit of fasting plasma glucose level defined by oral glucose tolerance test in Japanese subjects. Diabetes Res Clin Pract 99: 272-276, 2013.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
18. Japan Diabetes Society. Treatment guideline for diabetes 2004-2005 (in Japanese).
19. Ono E, Shiratori Y, Okudaira T, et al. Platelete count reflects stage of chronic hepatitis C. Hepatol Res 15: 192-200, 1999.
20. Japanese Society of Nephrology. Clinical practice guide book for diagnosis and treatment of chronic kidney disease 2012. Nippon Jinzou Gakkai Zasshi 54: 1031-1189, 2012 (in Japanese).
21. Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 11: 41-50, 2007.
22. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470, 1999.
23. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 33: e93, 2010.
24. Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults: definition, prevalence, β-cell function, and treatment. Diabetes 54(Suppl 2): S68-S72, 2005.
25. Rickels MR, Bellin M, Toledo FG, et al; PancreasFest Recommendation Conference Participants. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology 13: 336-342, 2013.
26. Fadda GZ, Thanakitcharu P, Comunale R, Lipson LG, Massry SG. Impaired potassium-induced insulin secretion in chronic renal failure. Kidney Int 40: 413-417, 1991.
27. Petrides AS, Stanley T, Matthews DE, Vogt C, Bush AJ, Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 28: 141-149, 1988.
28. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-10, 2002.
29. Uetani E, Tabara Y, Igase M, et al. Liver enzyme and adipocytokine profiles are synergistically associated with insulin resistance: the J-SHIPP study. J Atheroscler Thromb 19: 577-584, 2012.
30. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 66: S37-S43, 2004.